Literature DB >> 9681793

Acute respiratory distress syndrome due to all-trans retinoic acid.

D Gruson, G Hilbert, J M Boiron, L Portel, P Cony-Makoul, J Reiffers, G Gbikpi-Benissan, J P Cardinaud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681793     DOI: 10.1007/s001340050632

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  All-trans-retinoic acid in acute promyelocytic leukemia.

Authors:  M S Tallman; J W Andersen; C A Schiffer; F R Appelbaum; J H Feusner; A Ogden; L Shepherd; C Willman; C D Bloomfield; J M Rowe; P H Wiernik
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results.

Authors:  S Castaigne; C Chomienne; M T Daniel; P Ballerini; R Berger; P Fenaux; L Degos
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

3.  Fatal all-trans retinoic acid pneumonitis.

Authors:  K Smith-Whitley; B Lange
Journal:  Ann Intern Med       Date:  1993-03-15       Impact factor: 25.391

4.  The "retinoic acid syndrome" in acute promyelocytic leukemia.

Authors:  S R Frankel; A Eardley; G Lauwers; M Weiss; R P Warrell
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

5.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

6.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Authors:  R P Warrell; S R Frankel; W H Miller; D A Scheinberg; L M Itri; W N Hittelman; R Vyas; M Andreeff; A Tafuri; A Jakubowski
Journal:  N Engl J Med       Date:  1991-05-16       Impact factor: 91.245

  6 in total
  2 in total

Review 1.  Leukocyte homing, fate, and function are controlled by retinoic acid.

Authors:  Yanxia Guo; Chrysothemis Brown; Carla Ortiz; Randolph J Noelle
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

Review 2.  Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

Authors:  Bobbak Vahid; Paul E Marik
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.